CD44 and neoplasm: created PDAD@F68‐HA‐DOX nanoprobes that combine pH‐responsive fluorescence and FRET‐based imaging for precise tumor visualization, while utilizing hyaluronic acid for CD44‐mediated targeting and HAase‐triggered DOX release to achieve selective tumor cell apoptosis with minimal impact on normal tissues.[240] Feng et al.